Podcast: ePRO explained
Episode three of The Zelta Podcast series looks at the current state of play for ePRO in the clinical trials…
All articles by Alexander Love
Alexander Love
-
-
How ICH E6 (R3) is changing clinical trials
The latest ICH E6 (R3) guidelines could transform how clinical studies are built and operated. The updated ICH E6 (R3)…
-
The unsustainability of clinical trials and need for transformative change
With pressures only intensifying on clinical trials, there are major concerns that current models are inefficient and unsustainable. Insight from…
-
How to remain a top CDMO in ADC-led oncology
Contract development and manufacturing organisations (CDMOs) worldwide are facing a multitude of challenges, which are heightened considerably in oncology by…
-
Cell and gene therapy: The vital role of logistics
Cell and gene therapies (CGT) offer hope to patients living with life-threatening conditions where limited treatment options may be available…
-
Podcast: The benefits of blockchain in healthcare
One of the key advantages of blockchain is that it removes the need for patients to provide the same information…
-
Podcast: AI and Supervised Machine Learning in Clinical Trials – Part 2
In episode two of The Zelta Podcast, we continue our conversation about AI and supervised machine learning in clinical trials…
-
ePRO and eCOA: Digital solutions driving clinical trials engagement
Recruiting enough participants and keeping them engaged through lengthy clinical trials is increasingly challenging. In fact, more than 80% of…
-
How the cell and gene therapy market is taking shape
Cell and gene therapy (C>) represents a major advance in medical treatments by directly targeting the root causes of diseases…
-
Podcast: AI and Supervised Machine Learning in Clinical Trials – Ep1
AI and supervised machine learning have considerable benefits for clinical trials. The first episode in this GlobalData-produced series by Zelta…